HASSANEIN WALEED H

PrivateCIK: 1430466
Location

ANDOVER, MA

HASSANEIN WALEED H (President & CEO) sold 12.3% of their position (8.63K shares) of TRANSMEDICS GROUP, INC. on the open market

Open‑market sale worth $1.14M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 4 sales
InsiderHASSANEIN WALEED HCIK 1430466
IssuerTRANSMEDICS GROUP, INC.CIK 1756262
DirectorOfficer· President & CEO
Since May 2019
-8.63K
Net shares
Net seller
$1.14M
Total sold
4
Open market trades
0B · 4S
6
Total transactions
8.63K acquired · 17.25K disposed
Non-Derivative Transactions5

Common Stock

Direct
M · Option Exercise

Shares

+8.63K

Price / share

$13.28

Trade value

$114.54K

% of position

14.0%
10/15/2024
61.64K70.27K

Common Stock

Direct
S · Sale

Shares

3.61K

Price / share

$131.91

Trade value

$475.80K

% of position

5.1%
10/15/2024
70.27K66.66K

Common Stock

Direct
S · Sale

Shares

3.52K

Price / share

$132.82

Trade value

$467.26K

% of position

5.3%
10/15/2024
66.66K63.14K

Common Stock

Direct
S · Sale

Shares

1.20K

Price / share

$134.23

Trade value

$161.08K

% of position

1.9%
10/15/2024
63.14K61.94K

Common Stock

Direct
S · Sale

Shares

300.00

Price / share

$135.04

Trade value

$40.51K

% of position

0.5%
10/15/2024
61.94K61.64K
Total

Net shares

+0.00

Net value

-$1.03M

Derivative Transactions1

Stock Option (Right to Buy)

Direct
M · Option Exercise
Converts to

Common Stock

8.63K shares

Shares

8.63K

Strike price

13.28

Held after

96.25K

Exercisable

10/15/2024
Non-Derivative Holdings (Post-Transaction)1

Common Stock

Indirect
Shares owned469.36K
Total
469.36K indirect469.36K
Derivative Holdings (Post-Transaction)0
No derivative holdings reported
HASSANEIN WALEED H — Insider Transaction (Form 4) Filed Oct 17, 2024 | Finecho